Janux Therapeutics, Inc. (JANX) Return on equity 2021–2025
Janux Therapeutics, Inc. (JANX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-11.9%FY2025 · since FY2021: -8.9% → -11.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -11.9% | -5.1 pp |
| FY2024 | -6.7% | +10.2 pp |
| FY2023 | -16.9% | +2.7 pp |
| FY2022 | -19.7% | -10.7 pp |
| FY2021 | -8.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice